Jennifer Kuzma

Sep 7, 2022

Exploring the Social, Ethical Sides of Microbiome Engineering

NC State will play a key role in a new National Science Foundation center by examining the societal, ethical and policy implications of microbiome engineering advancements.

Sep 29, 2021

What to Know About GMOs

NC State biotech policy expert Jennifer Kuzma answers top questions about genetically modified organisms.

Aug 2, 2019

GES Center Awarded Half-Million Dollar Grant to Study Responsible Innovation of Food Nanotechnology

GES Center director Jennifer Kuzma and senior research scholar Khara Grieger will lead a two-year, USDA-funded study of responsible innovation of food nanotechnology.

Nov 28, 2018

Kudos to Kuzma: Distinguished Professor Named AAAS Fellow

Jennifer Kuzma has been elected as a fellow of the American Association for the Advancement of Science. Kuzma is the college's Goodnight-North Carolina GlaxoSmithKline Foundation Distinguished Professor in Social Sciences and co-directs NC State's Genetic Engineering and Society Center.

Mar 27, 2017

Are we prepared for our gene altered future?

The impending genetic boom goes beyond CRISPR and could have very wide-reaching implications — from feeding billions, to curing disease, to improving animal welfare. Those are the upsides. They could also have dire unintended consequences, for human health or even by disrupting entire ecosystems. Jennifer Kuzma, School of Public and International Affairs, featured.

Sep 16, 2016

Mosquitoes, Zika and Biotech Regulation

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology.

May 2, 2016

Kuzma Named to National Committee on Biotechnology

NC State University professor Jennifer Kuzma will lend her expertise to a national committee studying the future of genetic engineering. The National Academy of Sciences, Engineering and Medicine recently named Kuzma to the Committee on Future Biotechnology Products and Opportunities to Enhance Capabilities of the Biotechnology Regulatory System.